skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 223  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: language: English remove language: Russian remove Japanese remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002
Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002
Material Type:
Article 		Add to My Research

Intensive Chemotherapy for Childhood Acute Lymphoblastic Leukemia: Results of the Randomized Intercontinental Trial ALL IC-BFM 2002

Journal of clinical oncology, 2014-01, Vol.32 (3), p.174-184 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2013.48.6522 ;PMID: 24344215

Full text available

Citations Cited by
2
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Material Type:
Article 		Add to My Research

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

Annals of the rheumatic diseases, 2010-10, Vol.69 (10), p.1809-1815 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2010 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;ISSN: 1468-2060 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2009.114264 ;PMID: 20551155 ;CODEN: ARDIAO

Full text available

Citations Cited by
3
Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study
Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study
Material Type:
Article 		Add to My Research

Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study

Annals of oncology, 2014-07, Vol.25 (7), p.1340-1346 [Peer Reviewed Journal]

2014 THE AUTHORS ;2015 INIST-CNRS ;The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. ;The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. 2014 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdu110 ;PMID: 24608196

Full text available

Citations Cited by
4
Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case–control studies
Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case–control studies
Material Type:
Article 		Add to My Research

Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case–control studies

International journal of cancer, 2012-09, Vol.131 (5), p.1210-1219 [Peer Reviewed Journal]

Copyright © 2011 UICC. ;ISSN: 0020-7136 ;ISSN: 1097-0215 ;EISSN: 1097-0215 ;DOI: 10.1002/ijc.27339 ;PMID: 22052329

Digital Resources/Online E-Resources

Citations Cited by
5
Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium
Material Type:
Article 		Add to My Research

Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

American journal of epidemiology, 2013-09, Vol.178 (5), p.679-690 [Peer Reviewed Journal]

2014 INIST-CNRS ;Copyright Oxford Publishing Limited(England) Sep 1, 2013 ;The Author 2013. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2013 ;ISSN: 0002-9262 ;EISSN: 1476-6256 ;DOI: 10.1093/aje/kwt029 ;PMID: 23817919 ;CODEN: AJEPAS

Full text available

Citations Cited by
6
Prognostic Value of Reading-to-Reading Blood Pressure Variability Over 24 Hours in 8938 Subjects From 11 Populations
Prognostic Value of Reading-to-Reading Blood Pressure Variability Over 24 Hours in 8938 Subjects From 11 Populations
Material Type:
Article 		Add to My Research

Prognostic Value of Reading-to-Reading Blood Pressure Variability Over 24 Hours in 8938 Subjects From 11 Populations

Hypertension (Dallas, Tex. 1979), 2010-04, Vol.55 (4), p.1049-1057 [Peer Reviewed Journal]

2010 American Heart Association, Inc. ;2015 INIST-CNRS ;ISSN: 0194-911X ;ISSN: 1524-4563 ;EISSN: 1524-4563 ;DOI: 10.1161/HYPERTENSIONAHA.109.140798 ;PMID: 20212270 ;CODEN: HPRTDN

Full text available

Citations Cited by
7
Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study
Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study
Material Type:
Article 		Add to My Research

Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study

Clinical cancer research, 2014-01, Vol.20 (2), p.511-521 [Peer Reviewed Journal]

2015 INIST-CNRS ;2014 AACR. ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.ccr-13-0239 ;PMID: 24443618 ;CODEN: CCREF4

Full text available

Citations Cited by
8
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
Material Type:
Article 		Add to My Research

Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007

Clinical microbiology and infection, 2011-12, Vol.17 (12), p.1859-1867 [Peer Reviewed Journal]

2011 European Society of Clinical Infectious Diseases ;2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases ;2015 INIST-CNRS ;2011 The Authors. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases. ;ISSN: 1198-743X ;EISSN: 1469-0691 ;DOI: 10.1111/j.1469-0691.2010.03456.x ;PMID: 21199154

Digital Resources/Online E-Resources

Citations Cited by
9
European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis
European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis
Material Type:
Article 		Add to My Research

European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis

Annals of the Rheumatic Diseases, 2011-04, Vol.70 (4), p.563-570 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2015 INIST-CNRS ;Copyright: 2011 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2010.139105 ;PMID: 21216817 ;CODEN: ARDIAO

Full text available

Citations Cited by
10
Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer
Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer
Material Type:
Article 		Add to My Research

Randomized Phase II Study of Erlotinib Plus Tivantinib Versus Erlotinib Plus Placebo in Previously Treated Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3307-3315 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2010.34.0570 ;PMID: 21768463

Full text available

Citations Cited by
11
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure
Material Type:
Article 		Add to My Research

Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure

Blood, 2012-04, Vol.119 (15), p.3403-3412 [Peer Reviewed Journal]

2012 American Society of Hematology ;2015 INIST-CNRS ;2012 by The American Society of Hematology 2012 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2011-11-390120 ;PMID: 22371878

Full text available

Citations Cited by
12
Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer
Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer
Material Type:
Article 		Add to My Research

Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer

Annals of oncology, 2014-01, Vol.25 (1), p.107-116 [Peer Reviewed Journal]

2013 European Society for Medical Oncology ;2015 INIST-CNRS ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdt523 ;PMID: 24356622

Full text available

Citations Cited by
13
Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations
Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations
Material Type:
Article 		Add to My Research

Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations

Journal of hypertension, 2010-10, Vol.28 (10), p.2036 [Peer Reviewed Journal]

ISSN: 1473-5598 ;EISSN: 1473-5598 ;DOI: 10.1097/hjh.0b013e32833b49fe ;PMID: 20520575

Digital Resources/Online E-Resources

Citations Cited by
14
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial
Material Type:
Article 		Add to My Research

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial

The Lancet (British edition), 2011-08, Vol.378 (9792), p.676-683 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 20-Aug 26, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)61126-4 ;PMID: 21856481 ;CODEN: LANCAO

Full text available

Citations Cited by
15
Hsp70-Bag3 Interactions Regulate Cancer-Related Signaling Networks
Hsp70-Bag3 Interactions Regulate Cancer-Related Signaling Networks
Material Type:
Article 		Add to My Research

Hsp70-Bag3 Interactions Regulate Cancer-Related Signaling Networks

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (17), p.4731-4740 [Peer Reviewed Journal]

2015 INIST-CNRS ;2014 American Association for Cancer Research. ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/0008-5472.can-14-0747 ;PMID: 24994713 ;CODEN: CNREA8

Full text available

Citations Cited by
16
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe
Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe
Material Type:
Article 		Add to My Research

Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe

International journal of cancer, 2013-02, Vol.132 (4), p.854 [Peer Reviewed Journal]

Copyright © 2012 UICC. ;EISSN: 1097-0215 ;DOI: 10.1002/ijc.27713 ;PMID: 22752992

Digital Resources/Online E-Resources

Citations Cited by
17
Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group
Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group
Material Type:
Article 		Add to My Research

Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group

Journal of clinical oncology, 2013-02, Vol.31 (5), p.599-607 [Peer Reviewed Journal]

2014 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.43.7384 ;PMID: 23319696

Full text available

Citations Cited by
18
Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer
Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer
Material Type:
Article 		Add to My Research

Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2–Overexpressing Metastatic Breast Cancer

Journal of clinical oncology, 2013-06, Vol.31 (16), p.1947-1953 [Peer Reviewed Journal]

2014 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2011.40.5241 ;PMID: 23509322

Full text available

Citations Cited by
19
Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer
Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer
Material Type:
Article 		Add to My Research

Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer

Annals of oncology, 2006-08, Vol.17 (8), p.1263-1268 [Peer Reviewed Journal]

2006 INIST-CNRS ;Copyright Oxford University Press(England) Aug 2006 ;ISSN: 0923-7534 ;EISSN: 1569-8041 ;DOI: 10.1093/annonc/mdl104 ;PMID: 16740598

Full text available

Citations Cited by
20
The quantitative EEG theta/beta ratio in attention deficit/hyperactivity disorder and normal controls: sensitivity, specificity, and behavioral correlates
The quantitative EEG theta/beta ratio in attention deficit/hyperactivity disorder and normal controls: sensitivity, specificity, and behavioral correlates
Material Type:
Article 		Add to My Research

The quantitative EEG theta/beta ratio in attention deficit/hyperactivity disorder and normal controls: sensitivity, specificity, and behavioral correlates

Psychiatry research, 2012-08, Vol.198 (3), p.482 [Peer Reviewed Journal]

Copyright © 2012 Elsevier Ltd. All rights reserved. ;EISSN: 1872-7123 ;DOI: 10.1016/j.psychres.2011.12.041 ;PMID: 22425468

Digital Resources/Online E-Resources

Citations Cited by

Results 1 - 20 of 223  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1997  (13)
  2. 1997 To 2001  (38)
  3. 2002 To 2006  (54)
  4. 2007 To 2012  (88)
  5. After 2012  (31)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait